<DOC>
	<DOCNO>NCT01149824</DOCNO>
	<brief_summary>In study , aim determine active tolerable sublingual dose ( range 100 4000 µg ) Salvinorin A ( SA ) experience subject . This study ascending-dose , placebo-controlled , single-site design 8 Salvia-experienced subject . Subjects receive SA dose 0-4000 µg . Doses separate least one day . The first two dos ( 0 100µg ) double-blinded last four ( 250 , 500 , 1000 , 2000 4000µg ) single-blind .</brief_summary>
	<brief_title>Placebo Controlled Study Sublingual Salvinorin A</brief_title>
	<detailed_description />
	<criteria>Male female , age 2145 Experienced hallucinogenic amount SA Good physical mental health Able give adequate inform consent Any medical psychiatric condition , investigator ' opinion , would preclude safe consistent participation Significant acute chronic medical disease Female pregnant , lactate , plan become pregnant study period within one month study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Salvia divinorum</keyword>
	<keyword>Salvinorin A</keyword>
</DOC>